Liofen 25 Tablet contains Baclofen 25 mg, a centrally acting skeletal muscle relaxant primarily used to treat spasticity associated with conditions such as multiple sclerosis, spinal cord injuries, and other neurological disorders. Baclofen exerts its therapeutic effect by stimulating GABA-B receptors in the central nervous system, leading to inhibition of excitatory neurotransmitter release and subsequent reduction in muscle spasticity and rigidity. Liofen 25 is indicated for the management of muscle spasms, spasticity, and associated pain, improving mobility and functional ability in affected patients. The tablet is administered orally, with dosage individualized based on patient response and clinical condition, typically starting at a low dose and gradually titrated to minimize side effects. Common adverse effects include drowsiness, dizziness, weakness, and gastrointestinal disturbances, which are generally dose-dependent and reversible upon discontinuation or dose adjustment. Caution is advised in patients with renal impairment, epilepsy, or a history of hypersensitivity to Baclofen. Abrupt withdrawal should be avoided to prevent withdrawal symptoms such as hallucinations or seizures. Liofen 25 should be used under medical supervision, with regular monitoring to assess therapeutic efficacy and tolerability. It is contraindicated in patients with hypersensitivity to Baclofen or its excipients.